Prospective observational study of the impacts of heated tabacco products on lung function over time in patients with chronic obstructive pulmonary disease
Not Applicable
Recruiting
- Conditions
- COPD
- Registration Number
- JPRN-UMIN000047377
- Lead Sponsor
- Ministry of Health, Labour and Welfare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who cannot respond to pulmonary function tests, questionnaires, etc. 2.Patients with lung diseases other than COPD and bronchial asthma (e.g., lung cancer, interstitial pneumonia) 3.Patients deemed ineligible by the attending physician 4.Patients who could not give consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link heated tobacco product use to COPD progression in observational studies?
How do heated tobacco products compare to standard-of-care treatments in COPD patient lung function decline?
Which biomarkers correlate with COPD exacerbation risk in heated tobacco product users?
What are the potential adverse pulmonary effects of long-term heated tobacco product exposure in COPD patients?
Are there specific COPD subtypes where heated tobacco products show differential impacts on FEV1 and FVC parameters?